<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02989038</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00075882</org_study_id>
    <secondary_id>R01DA042532</secondary_id>
    <nct_id>NCT02989038</nct_id>
  </id_info>
  <brief_title>Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers</brief_title>
  <acronym>NicRed</acronym>
  <official_title>Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate reactions to, and choices to self-administer,
      cigarette smoke with varying nicotine content among low-frequency, non-dependent
      adolescent/young adult smokers between the ages of 18-25 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will undergo three sessions in which their reactions to fixed doses of smoke
      from investigational cigarettes with three different nicotine contents (15.8 mg/gram of
      tobacco, 2.5 mg/g, and .4 mg/g) will be assessed. Following the third fixed-dose session,
      participants will return to the lab to choose one of the cigarettes to self-administer.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective reactions to fixed doses of tobacco smoke</measure>
    <time_frame>Immediately after puff administration of each study cigarette</time_frame>
    <description>Smoking Effects Questionnaire ratings following administration of puffs for NNC, INC, and VLNC cigarettes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cigarette choice</measure>
    <time_frame>30 minutes after sampling all 3 study cigarettes</time_frame>
    <description>Participants will choose which of the three cigarettes they prefer to smoke by ranking each of the three cigarette conditions using a 1-3 scale where 1 is the cigarette that they most desire to smoke and 3 is the cigarette that they least desire to smoke.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mood and Affect</measure>
    <time_frame>Immediately after puff administration of each study cigarette</time_frame>
    <description>The Positive and Negative Affect Schedule (PANAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood and Affect</measure>
    <time_frame>Immediately after puff administration of each study cigarette</time_frame>
    <description>Minnesota Nicotine Withdrawal Scale (MNWS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking topography - Change in Carbon Monoxide (CO) values (in parts per million, ppm) following puff administration</measure>
    <time_frame>Immediately after puff administration of each study cigarette</time_frame>
    <description>CO values (in ppm) will be obtained using a handheld CO monitor prior to puff administration and 5 minutes after completion of cigarette puff administration. The difference in values will provide a CO boost value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking topography - number of puffs</measure>
    <time_frame>During self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)</time_frame>
    <description>number of puffs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking topography - interpuff interval</measure>
    <time_frame>During self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)</time_frame>
    <description>Interpuff interval (in seconds) will be calculated using video recordings of self-administration of chosen cigarette</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>NNC, INC, VLNC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal Nicotine Content (NNC), Intermediate Nicotine Content (INC), Very Low Nicotine Content (VLNC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NNC, VLNC, INC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal Nicotine Content, Very Low Nicotine Content, Intermediate Nicotine Content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>INC, VLNC, NNC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intermediate Nicotine Content, Very Low Nicotine Content, Normal Nicotine Content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>INC, NNC, VLNC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intermediate Nicotine Content, Normal Nicotine Content, Very Low Nicotine Content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VLNC, NNC, INC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Very Low Nicotine Content, Normal Nicotine Content, Intermediate Nicotine Content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VLNC, INC, NNC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Very Low Nicotine Content, Intermediate Nicotine Content, Normal Nicotine Content</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Very Low Nicotine Content Cigarettes</intervention_name>
    <description>cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield</description>
    <arm_group_label>NNC, INC, VLNC</arm_group_label>
    <arm_group_label>NNC, VLNC, INC</arm_group_label>
    <arm_group_label>INC, VLNC, NNC</arm_group_label>
    <arm_group_label>INC, NNC, VLNC</arm_group_label>
    <arm_group_label>VLNC, NNC, INC</arm_group_label>
    <arm_group_label>VLNC, INC, NNC</arm_group_label>
    <other_name>Tobacco</other_name>
    <other_name>Cigarettes</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intermediate Nicotine Content Cigarettes</intervention_name>
    <description>cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield</description>
    <arm_group_label>NNC, INC, VLNC</arm_group_label>
    <arm_group_label>NNC, VLNC, INC</arm_group_label>
    <arm_group_label>INC, VLNC, NNC</arm_group_label>
    <arm_group_label>INC, NNC, VLNC</arm_group_label>
    <arm_group_label>VLNC, NNC, INC</arm_group_label>
    <arm_group_label>VLNC, INC, NNC</arm_group_label>
    <other_name>Tobacco</other_name>
    <other_name>Cigarettes</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Nicotine Content Cigarettes</intervention_name>
    <description>cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield</description>
    <arm_group_label>NNC, INC, VLNC</arm_group_label>
    <arm_group_label>NNC, VLNC, INC</arm_group_label>
    <arm_group_label>INC, VLNC, NNC</arm_group_label>
    <arm_group_label>INC, NNC, VLNC</arm_group_label>
    <arm_group_label>VLNC, NNC, INC</arm_group_label>
    <arm_group_label>VLNC, INC, NNC</arm_group_label>
    <other_name>Tobacco</other_name>
    <other_name>Cigarettes</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  generally healthy

          -  between the ages of 18-25

          -  use nicotine or tobacco products between 1-15 days/month for at least 6 months

          -  smokes at least 10 cigarettes/month

          -  no unstable or significant medical or psychiatric conditions

          -  breath alcohol value=0.000

          -  able to provide contact information for two individuals who can corroborate smoking
             status

        Exclusion Criteria:

          -  use of illegal drugs as measured by urine drug screen (excluding THC)

          -  serious quit attempt in the past 3 months

          -  plans to quit smoking in the next 2 months

          -  current use of nicotine replacement therapy or other tobacco cessation products

          -  inability to attend all required experimental sessions

          -  blood pressure &gt;160/100 mmHg

          -  pregnant, trying to become pregnant, or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francis J McClernon, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rachel Kozink, M.S.</last_name>
    <phone>919-668-2963</phone>
    <email>rachel.kozink@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Kozink</last_name>
      <email>rachel.kozink@duke.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2016</study_first_submitted>
  <study_first_submitted_qc>December 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2016</study_first_posted>
  <last_update_submitted>July 25, 2017</last_update_submitted>
  <last_update_submitted_qc>July 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>smoker</keyword>
  <keyword>young adult</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

